Industry / Switzerland
Huge Potential For Cytos Pipeline
August 2008 | Company News AlertBiotechnology firm Cytos is to link up with US pharmaceutical giant Pfizer in the development of vaccines for a number of human diseases, the Swiss firm announced on August 15 2008. In addition, the company has said it expects to sell the rights to an experimental vaccine for hypertension during the second half of 2009. With Cytos attracting interest from multinationals, BMI takes a look at the opportunities that may lay ahead for the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
